Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer
- PMID: 30613477
- PMCID: PMC6319890
- DOI: 10.21037/tcr.2017.02.35
Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer
Conflict of interest statement
Conflicts of Interest: The author has no conflicts of interest to declare.
Figures
Comment on
-
XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer.Nature. 2016 Oct 6;538(7623):114-117. doi: 10.1038/nature19771. Epub 2016 Sep 28. Nature. 2016. PMID: 27680702 Free PMC article.
References
-
- Cook A, Bono F, Jinek M, et al. Structural biology of nucleocytoplasmic transport. Annu Rev Biochem 2007;76:647–71. - PubMed
-
- Kau TR, Way JC, Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 2004;4:106–17. - PubMed
-
- Kudo N, Khochbin S, Nishi K, et al. Molecular cloning and cell cycle-dependent expression of mammalian CRM1, a protein involved in nuclear export of proteins. J Biol Chem 1997;272:29742–51. - PubMed
-
- Lu C, Figueroa JA, Liu Z, et al. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection. Curr Cancer Drug Targets 2015;15:575–92. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources